Statistically Significant Reduction of Biological Pace of Aging: Case Study on NOVOS Core + Boost

NOVOS initiated a case study from February 2022 to August 2022. For the study, 12 participants were provided with an epigenetic test kit (the same test behind NOVOS Age), plus […]

Read more

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.